A brief history of treatments for chilhood acute lymphoblastic leukaemia

被引:1
|
作者
Leverger, Guy
Baruchel, Andre [1 ,2 ]
Schaison, Gerard
机构
[1] Hop Armand Trousseau, F-75012 Paris, France
[2] Univ Paris 06, UMR 5938, F-75252 Paris 05, France
来源
BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE | 2009年 / 193卷 / 07期
关键词
PRECURSOR CELL; LYMPHOBLASTIC; LEUKEMIA-LYMPHOMA; CHILD; LEUKEMIA/THERAPEUTICS; MINIMAL RESIDUAL DISEASE; CHILDREN; CLASSIFICATION; THERAPY; PROGNOSIS; FRANCE;
D O I
10.1016/S0001-4079(19)32439-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Acute lymphoblastic leukaemia is the most frquent childhood malignancy The first effective drugs, which provided only short-lived complete remission, started to be used in the 1950s All the effective drugs currently in use were discovered in the 1960s, when the first multidrug chemotherapy regumens were shown to confer prolonged complete remission, raising the possibility of a cure Simultaneously, progress in our knowledge of leukaemic cells, and the identification of prognostic factors such as leukocytosis, age, cytogenetic and molecular abnormalities, and the early therapeutic response of leukaemic cells, led to randomized multicenter national and international trials As a result, the chance of cure increased gradually over the last three decades In rich countries, the overall survival rate among children with acute lymphoblastic leukaemia now reaches 85 to 90%
引用
收藏
页码:1495 / 1499
页数:5
相关论文
共 50 条
  • [21] Acute lymphoblastic leukaemia: diagnosis and classification
    Kebriaei, P
    Anastasi, J
    Larson, RA
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2002, 15 (04) : 597 - 621
  • [22] Expression of Aberrant Markers and its Association with Remission Postinduction Therapy in Acute Lymphoblastic Leukaemia and Acute Myeloid Leukaemia
    Shwetha, Subbaramaiah
    Lokanatha, Dasappa
    Sureshbabu, M. C.
    Lokesh, K. N.
    Rudresha, A. H.
    Rajeev, L. K.
    Saldanha, Smitha C.
    Jacob, Linu Abraham
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2021, 15 (07)
  • [23] Antibody-based therapies in B-cell lineage acute lymphoblastic leukaemia
    Le Jeune, Caroline
    Thomas, Xavier
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2015, 94 (02) : 99 - 108
  • [24] Survival in adult acute lymphoblastic leukaemia (ALL): A report from the Swedish ALL Registry
    Lennmyr, Emma
    Karlsson, Karin
    Ahlberg, Lucia
    Garelius, Hege
    Hulegardh, Erik
    Izarra, Antonio S.
    Joelsson, Joel
    Kozlowski, Piotr
    Moicean, Andreea
    Tomaszewska-Toporska, Beata
    Lubking, Anna
    Hallbook, Helene
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2019, 103 (02) : 88 - 98
  • [25] Adult acute lymphoblastic leukaemia in Denmark. A national population-based retrospective study on acute lymphoblastic leukaemia in Denmark 1998-2008
    Toft, Nina
    Schmiegelow, Kjeld
    Klausen, Tobias W.
    Birgens, Henrik
    BRITISH JOURNAL OF HAEMATOLOGY, 2012, 157 (01) : 97 - 104
  • [26] Adolescents and young adults with acute lymphoblastic leukaemia: A new frontier?
    Baruchel, Andre
    EJC SUPPLEMENTS, 2007, 5 (05): : 203 - 208
  • [27] L-asparaginase induced hyperlipidaemia in acute lymphoblastic leukaemia
    Nesheli, Hassan Mahmoodi
    Tamaddoni, Ahmad
    Nesheli, Mohsen Mahmoodi
    Yahyai, Alireza
    Khabiri, Fariba
    Hosseinzadeh, Fatemeh
    Moghaddam, Tahereh Galini
    JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION, 2013, 63 (03) : 324 - 326
  • [28] Recent advances in the treatment and understanding of childhood acute lymphoblastic leukaemia
    Rubnitz, JE
    Pui, CH
    CANCER TREATMENT REVIEWS, 2003, 29 (01) : 31 - 44
  • [29] The changing landscape of treatment options in childhood acute lymphoblastic leukaemia
    Micallef, Benjamin
    Nistico, Robert
    Sarac, Sinan B.
    Bjerrum, Ole W.
    Butler, Dianne
    Bartolo, Nicolette Sammut
    Serracino-Inglott, Anthony
    Borg, John Joseph
    DRUG DISCOVERY TODAY, 2022, 27 (05) : 1483 - 1494
  • [30] History of treatment and long-term outcome in children with acute lymphoblastic leukaemia in Serbia
    Micic D.
    Slavkovic B.
    Rasovic Gvozdenovic N.
    Kuzmanovic M.
    Dokmanovic L.
    Krstovski N.
    Skoric D.
    Konstantinidis N.
    Kostic G.
    Predojevic J.
    Janic D.
    memo - Magazine of European Medical Oncology, 2011, 4 (3) : 174 - 177